Literature DB >> 16399594

Regression models for hazard rates versus cumulative incidence probabilities in hematopoietic cell transplantation data.

Brent R Logan1, Mei-Jie Zhang, John P Klein.   

Abstract

In this article, we consider methods of regression modeling in the competing risks setting commonly encountered in analyzing stem cell transplantation data. We clarify the distinction between modeling the cause-specific hazard rate and modeling the cumulative incidence probability or function, and we review regression techniques for both types of quantities. We apply them to 2 examples: 1 comparing engraftment and 1 examining relapse. These examples illustrate that different conclusions may result depending on the type of regression model used for comparing treatments. Finally, we show how these discrepancies occur because 2 different characteristics of the time-to-event distribution are being modeled.

Mesh:

Year:  2006        PMID: 16399594     DOI: 10.1016/j.bbmt.2005.09.005

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  14 in total

1.  SAS macros for estimation of direct adjusted cumulative incidence curves under proportional subdistribution hazards models.

Authors:  Xu Zhang; Mei-Jie Zhang
Journal:  Comput Methods Programs Biomed       Date:  2010-08-17       Impact factor: 5.428

2.  Treatment with GM-CSF secreting myeloid leukemia cell vaccine prior to autologous-BMT improves the survival of leukemia-challenged mice.

Authors:  Jenny Zilberberg; Thea M Friedman; Glenn Dranoff; Robert Korngold
Journal:  Biol Blood Marrow Transplant       Date:  2010-10-12       Impact factor: 5.742

3.  Insomnia symptoms are associated with an increased risk of type 2 diabetes mellitus among adults aged 50 and older.

Authors:  Wenqin Yao; Jia Luo; Xiaohui Yu; Wenjie Jiang; Dongfeng Zhang
Journal:  Sleep Breath       Date:  2021-09-26       Impact factor: 2.655

Review 4.  Clinical endpoints in allogeneic hematopoietic stem cell transplantation studies: the cost of freedom.

Authors:  Haesook T Kim; Philippe Armand
Journal:  Biol Blood Marrow Transplant       Date:  2013-01-07       Impact factor: 5.742

Review 5.  Review of multistate models in hematopoietic cell transplantation studies.

Authors:  Brent R Logan
Journal:  Biol Blood Marrow Transplant       Date:  2012-10-17       Impact factor: 5.742

6.  Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation.

Authors:  Matteo G Della Porta; Anna Gallì; Andrea Bacigalupo; Silvia Zibellini; Massimo Bernardi; Ettore Rizzo; Bernardino Allione; Maria Teresa van Lint; Pietro Pioltelli; Paola Marenco; Alberto Bosi; Maria Teresa Voso; Simona Sica; Mariella Cuzzola; Emanuele Angelucci; Marianna Rossi; Marta Ubezio; Alberto Malovini; Ivan Limongelli; Virginia V Ferretti; Orietta Spinelli; Cristina Tresoldi; Sarah Pozzi; Silvia Luchetti; Laura Pezzetti; Silvia Catricalà; Chiara Milanesi; Alberto Riva; Benedetto Bruno; Fabio Ciceri; Francesca Bonifazi; Riccardo Bellazzi; Elli Papaemmanuil; Armando Santoro; Emilio P Alessandrino; Alessandro Rambaldi; Mario Cazzola
Journal:  J Clin Oncol       Date:  2016-10-20       Impact factor: 44.544

7.  Analysis and design of randomised clinical trials involving competing risks endpoints.

Authors:  Bee-Choo Tai; Joseph Wee; David Machin
Journal:  Trials       Date:  2011-05-19       Impact factor: 2.279

Review 8.  Identification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime?

Authors:  Lara E Sucheston-Campbell; Alyssa Clay; Philip L McCarthy; Qianqian Zhu; Leah Preus; Marcelo Pasquini; Kenan Onel; Theresa Hahn
Journal:  Curr Hematol Malig Rep       Date:  2015-03       Impact factor: 3.952

9.  A Novel Risk Score to the Prediction of 10-year Risk for Coronary Artery Disease Among the Elderly in Beijing Based on Competing Risk Model.

Authors:  Long Liu; Zhe Tang; Xia Li; Yanxia Luo; Jin Guo; Haibin Li; Xiangtong Liu; Lixin Tao; Aoshuang Yan; Xiuhua Guo
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

10.  Nomograms for Differentiated Thyroid Carcinoma Patients Based on the Eighth AJCC Staging and Competing Risks Model.

Authors:  Chengzhuo Li; Fengshuo Xu; Qiao Huang; Didi Han; Shuai Zheng; Wentao Wu; Fanfan Zhao; Xiaojie Feng; Jun Lyu
Journal:  JNCI Cancer Spectr       Date:  2021-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.